Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2007

Adkins MW, Carson JJ, English CM, Ramey CJ, Tyler JK. The histone chaperone anti-silencing function 1 stimulates the acetylation of newly synthesized histone H3 in S-phase. J Biol Chem. 2007;282(2):1334-40.

Di Vizio D, Sotgia F, Williams TM, Hassan GS, Capozza F, Frank PG, et al. Caveolin-1 is required for the upregulation of fatty acid synthase (FASN), a tumor promoter, during prostate cancer progression. Cancer Biol Ther. 2007;6(8):1263-8.

A Crowson N, Magro C, Miller A, Mihm MC. The molecular basis of melanomagenesis and the metastatic phenotype. Semin Oncol. 2007;34(6):476-90.

Moreno-Bueno G, Fernandez-Marcos PJ, Collado M, Tendero MJ, Rodriguez-Pinilla SM, Garcia-Cao I, et al. Inactivation of the candidate tumor suppressor par-4 in endometrial cancer. Cancer Res. 2007;67(5):1927-34.

Singh S, Goyal A. The origin of echocardiography: a tribute to Inge Edler. Tex Heart Inst J. 2007;34(4):431-8.

Skeate RC, Wahi MM, Jessurun J, Connelly DP. Personal digital assistant-enabled report content knowledgebase results in more complete pathology reports and enhances resident learning. Hum Pathol. 2007;38(12):1727-35.

Valli T, Barthold SW, Ward JE, Brayton C, Nikitin A, Borowsky AD, et al. Over 60% of NIH extramural funding involves animal-related research. Vet Pathol. 2007;44(6):962-3, author reply 963-4.

Lu LJ, Sboner A, Huang YJ, Lu HX, Gianoulis TA, Yip KY, et al. Comparing classical pathways and modern networks: towards the development of an edge ontology. Trends Biochem Sci. 2007;32(7):320-31.

Ogino S, Meyerhardt JA, Kawasaki T, Clark JW, Ryan DP, Kulke MH, et al. CpG island methylation, response to combination chemotherapy, and patient survival in advanced microsatellite stable colorectal carcinoma. Virchows Arch. 2007;450(5):529-37.

Paik J-, Kollipara R, Chu G, Ji H, Xiao Y, Ding Z, et al. FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis. Cell. 2007;128(2):309-23.